Court of Appeal under presiding judge Klaus Grabinski overturned the PI. According to the court, it is likely that the patent-in-suitEP 4 108 782will be declared invalid in the main proceedings. This
In its first judgment, the UPC local division Lisbon has proven it is a force to be reckoned with. The judges dismissed Ericsson's application for a PI against AsusTek, but also commented on the
Celltrion will not face a PI from the Unified Patent Court against its biosimilar of Novartis' asthma drug Xolair. Today, Düsseldorf local division dismissed the PI application by Novartis and
Both the local and central divisions in Milan have rejected Insulet's PI applications due to doubts about the validity of the patent-in-suit. This is a setback in the company's fight over insulin
The Delhi Commercial Court issued a significant ruling in favour of Monster Energy Company in its ongoing trademark infringement case against Shree Parvati Fitness Hub Private Limited. The court grant...